MapTrek to Increase Activity Among Patients at Risk for Type 2 Diabetes

Completed · Not applicable

Conditions studied: Pre Diabetes, Obesity

In brief

The overarching objective of our work is to provide an inexpensive and scalable m-health tool to increase both volume and intensity of physical activity and reduce sedentary behavior in patients at risk for type 2 diabetes. The objective of this study is to pilot test MapTrek, a text-messaging based intervention.

Key facts

Study ID

NCT03193229

Run by

Philip Polgreen

People needed

430

Starts

2017-05-15

Expected to finish

2018-05-04

Last updated by the study team

2018-10-16

Who can join

Age: 21 and older, up to 80. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• At least 21 years old
• English speaker
• Have a smart phone with texting and internet capabilities
• No aversion to research studies
• No active mental health conditions
• 1) Have a BMI > or equal to 25 and a history of hemoglobin A1C level between 5.7 and 6.4%, or 2) have a BMI > or equal to 30.

You may not qualify if…

• Pregnancy
• Prisoner status
• Taking insulin or other diabetic medications

Where it is running

• Signal Center Innovation Lab — Coralville, Iowa, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.